Skip to main content
FEMY
NASDAQ Industrial Applications And Services

Femasys Faces $3.1M Lawsuit Over August Private Placement Terms

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.38
Mkt Cap
$19.933M
52W Low
$2.022
52W High
$22.2
52W Position info
18% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

FEMY sits 18% above its 52-week low of $2.022.

Summary

Femasys disclosed a $3.1 million lawsuit alleging its August 2026 private placement breached terms of secured convertible notes, triggering immediate repayment obligations.


Key Events · Legal and Risk Events · FEMY

  • Lawsuit Filed Over Private Placement

    Iroquois Master Fund and Iroquois Capital Investment Group filed a motion for summary judgment on September 2, 2026, seeking approximately $3.1 million plus 9% prejudgment interest from August 10, 2026.

  • Alleged Fundamental Transaction Breach

    Plaintiffs claim the August 10, 2026 private placement constituted a 'Fundamental Transaction' under Senior Secured Convertible Notes issued November 7, 2025, triggering immediate repayment.

  • Company Disputes Claims

    Femasys states the allegations are without merit and intends to defend the action vigorously; no loss estimate is currently determinable.

  • Registration of 28.1M Shares

    The prospectus registers 28,124,997 shares for resale by selling stockholders from the August 2026 private placement, including 5,013,559 common shares and 23,111,438 warrant-exercisable shares.


Analysis · FEMY · Industrial Applications And Services

The prospectus discloses that Iroquois Master Fund and Iroquois Capital Investment Group filed a motion for summary judgment on September 2, 2026, seeking approximately $3.1 million plus 9% prejudgment interest. The plaintiffs allege the August 10, 2026 private placement triggered a 'Fundamental Transaction' clause in Senior Secured Convertible Notes issued November 7, 2025, requiring immediate repayment. Femasys disputes the claims and intends to defend vigorously. This is a material legal risk not previously disclosed in the timeline, and it directly challenges the validity of the company's recent $30 million financing.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FEMY was trading at $2.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.9M. The 52-week trading range was $2.02 to $22.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Sep 03, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $2.18 info
Change: -$0.8629 (-28%) info
Market Cap: $18.233M info
FEMY
Aug 26, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $2.18 info
Change: -$0.7037 (-24%) info
Market Cap: $18.233M info
FEMY
Aug 19, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.18 info
Change: +$0.0271 (+1%) info
Market Cap: $18.233M info
FEMY
Aug 14, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $2.18 info
Change: -$0.1629 (-7%) info
Market Cap: $18.233M info
FEMY
Aug 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $2.18 info
Change: -$0.1629 (-7%) info
Market Cap: $18.233M info